Exogenous GLP-1 improves gastric compliance in a dose-dependent manner (Schirra et al., 2002), reduces the frequency and amplitude of gastric antrum and duodenum contraction, inhibits the contractile force of gastric antrum and duodenum, increases pyloric tension, and stimulates pyloric tetanic and phase motion (Schirra et al., 2000)
A compounded product is considered essentially a copy if it has the same API as a commercially available drug in the same, similar, or easily substitutable strength, and can be used by the same route of administration, unless the prescriber documents a patient-specific change that produces a significant difference
Tirzepatide is the first prescription drug to be approved for weight loss
Importing peptides from international sources involves additional risk
Mudgil is also a member of the Mount Sinai School of Medicine teaching faculty